-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives
Review
(2471) Views (666) Full article downloads
Authors: Francesco Chiarelli, Daniele Di Marzio
Published Date May 2008
Volume 2008:4(2) Pages 297 - 304
DOI: http://dx.doi.org/10.2147/VHRM.S993
Francesco Chiarelli, Daniele Di Marzio
Department of Pediatrics, University of Chieti, Italy
Abstract: Since their initial availability in 1997, the thiazolidinediones (TZDs) have become one of the most commonly prescribed classes of medications for type 2 diabetes. In addition to glucose control, the TZDs have a number of pleiotropic effects on myriad traditional and non-traditional risk factors for diabetes. TZDs may benefit cardiovascular parameters, such as lipids, blood pressure, inflammatory biomarkers, endothelial function and fibrinolytic state. In this review, we summarise the experimental, preclinical and clinical data regarding the effects of the TZDs in conditions for which they are indicated and discuss their potential in the treatment of other conditions.
Keywords: PPARγ, thiazolidinediones, rosiglitazone, pioglitazone, troglitazone
Readers of this article also read:
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years
Impact of nutrition on serum percentage in heifers
Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD)
Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
Corrigendum - Functional mobility and balance in community dwelling elderly submitted to multisensory versus strength exercises
Editorial
Erratum
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
